PeriphaGen is a biopharmaceutical company committed to the development of innovative products for difficult to treat neurologic disorders with unmet medical needs.
To find out more, view our corporate presentation.
How NET Works
Our Technology Our products, based on our Neuronal Therapeutic (NET) platform are unique in their ability to direct therapeutic gene expression in neurons for unparalleled treatment specificity without the side effects of standard systemic pharmaceuticals.
PeriphaGen NET products may lead to groundbreaking improvements in the treatment of neuropathic pain, prevention of neuropathy, and neuronal regeneration.
View Our Pipeline